Infliximab

SAN ANTONIO — In this video from the American College of Gastroenterology Annual Meeting, David T. Rubin, MD, section chief of Gastroenterology, Hepatology and Nutrition, and co-director of the Digestive Diseases Center at the University of Chicago Medicine, discusses his presentation on identifying and managing patients with high-risk ulcerative colitis.

Dermatologists performed the fewest number of biopsies to diagnose one skin cancer compared with other types of clinicians, according to researchers from University of Wisconsin-Madison and Mayo Clinic, in the top Healio Dermatology story last week.

For most patients with hidradenitis suppurativa, a dosage of at least 10 mg/kg of Remicade every 8 weeks will optimize treatment, according to findings published in Journal of the American Academy of Dermatology.

Physicians have an array of biologic agents available to treat patients with ulcerative colitis, but it is still unknown which therapies are superior, as well as which therapies work best in certain instances.

IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the originator drug among patients with ankylosing spondylitis, according to data published in The Lancet Rheumatology.

In patients with psoriasis, the median time between first and last biologic prescriptions was between 3.3 and 7 months with up to 50% of patients not prescribed a second prescription for the medication, according to researchers in Journal of Drugs in Dermatology.

Earlier this month, Healio Dermatology posted a compilation of eight popular reads to kickoff Psoriasis Action Month in psoriasis research, advocacy and FDA news.

ORLANDO — As rheumatology treatments continue to advance and grow more complex, the need for teamwork among physicians, nurse practitioners, registered nurses and other health care professionals has never been more important, according to Adam J. Brown, MD, of the Cleveland Clinic.